143 related articles for article (PubMed ID: 6467682)
1. Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases.
Manns M; Meyer zum Büschenfelde KH; Slusarczyk J; Dienes HP
Clin Exp Immunol; 1984 Sep; 57(3):600-8. PubMed ID: 6467682
[TBL] [Abstract][Full Text] [Related]
2. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
4. Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM).
Lenzi M; Bianchi FB; Cassani F; Pisi E
Clin Exp Immunol; 1984 Jan; 55(1):36-40. PubMed ID: 6692597
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
[TBL] [Abstract][Full Text] [Related]
6. Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.
Peakman M; Lobo-Yeo A; Mieli-Vergani G; Davies ET; Mowat AP; Vergani D
Clin Exp Immunol; 1987 Sep; 69(3):543-9. PubMed ID: 3665184
[TBL] [Abstract][Full Text] [Related]
7. Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Gruber R; Felber E; Pape GR; Höchtlen-Vollmar W; Riethmüller G
J Clin Lab Anal; 1994; 8(5):284-92. PubMed ID: 7807283
[TBL] [Abstract][Full Text] [Related]
8. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
[TBL] [Abstract][Full Text] [Related]
9. Counterimmunoelectrophoresis (CIE) for the detection of anti-liver-kidney microsome (LKM) antibodies in the sera of patients with chronic liver disease.
Lenzi M; Fusconi M; Selleri L; Caselli A; Cassani F; Bianchi FB; Pisi E
J Immunol Methods; 1988 Jul; 111(2):253-9. PubMed ID: 3397549
[TBL] [Abstract][Full Text] [Related]
10. Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: liver-kidney microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue.
Kyriatsoulis A; Manns M; Gerken G; Lohse AW; Ballhausen W; Reske K; Meyer zum Büschenfelde KH
Clin Exp Immunol; 1987 Oct; 70(1):53-60. PubMed ID: 3690894
[TBL] [Abstract][Full Text] [Related]
11. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis.
Czaja AJ; Manns MP; Homburger HA
Gastroenterology; 1992 Oct; 103(4):1290-5. PubMed ID: 1397887
[TBL] [Abstract][Full Text] [Related]
12. IgG subclass distribution of autoantibodies to glomerular basement membrane in Goodpasture's syndrome compared to other autoantibodies.
Weber M; Lohse AW; Manns M; Meyer zum Büschenfelde KH; Köhler H
Nephron; 1988; 49(1):54-7. PubMed ID: 3380219
[TBL] [Abstract][Full Text] [Related]
13. Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome autoantibody type 1.
Iijima Y; Kato T; Miyakawa H; Ogino M; Mizuno M; Sugihara K; Ando T; Fujiwara K; Orito E; Ueda R; Mizokami M
J Gastroenterol Hepatol; 2001 Jul; 16(7):782-8. PubMed ID: 11446887
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay.
Manns M; Meyer zum Büschenfelde KH; Hütteroth TH; Hess G
Clin Exp Immunol; 1980 Nov; 42(2):263-72. PubMed ID: 6781800
[TBL] [Abstract][Full Text] [Related]
15. Anti-GOR and hepatitis C virus in autoimmune liver diseases.
Michel G; Ritter A; Gerken G; Meyer zum Büschenfelde KH; Decker R; Manns MP
Lancet; 1992 Feb; 339(8788):267-9. PubMed ID: 1346282
[TBL] [Abstract][Full Text] [Related]
16. HBsAg-induced hypertrophic smooth endoplasmic reticulum as a target for liver-kidney microsomal (LKM) antibodies.
Ballardini G; Landi P; Busachi CA; Bianchi FB; Pisi E
Clin Exp Immunol; 1981 Mar; 43(3):599-604. PubMed ID: 7026097
[TBL] [Abstract][Full Text] [Related]
17. [Significance of autoantibodies in the diagnosis of non-A, non-B hepatitis].
Manns M; Arnold W; Meyer zum Büschenfelde KH
Leber Magen Darm; 1984 Sep; 14(5):211-5. PubMed ID: 6436603
[TBL] [Abstract][Full Text] [Related]
18. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.
Homberg JC; Andre C; Abuaf N
Clin Exp Immunol; 1984 Mar; 55(3):561-70. PubMed ID: 6368059
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
Todros L; Saracco G; Durazzo M; Abate ML; Touscoz G; Scaglione L; Verme G; Rizzetto M
Hepatology; 1995 Nov; 22(5):1374-8. PubMed ID: 7590650
[TBL] [Abstract][Full Text] [Related]
20. Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay and immunoblotting.
Manns M; Gerken G; Kyriatsoulis A; Trautwein C; Reske K; Meyer Zum Büschenfelde KH
Hepatology; 1987; 7(5):893-9. PubMed ID: 2443436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
